°øÁö : µµÄìÁõ±Ç°Å·¡¼Ò JASDAQ ½ºÅÄ´Ùµå ½ÃÀå ½Å±Ô »óÀå °ü·Ã ¾È³»

Global Information
ȸ»ç¼Ò°³ | ¹®ÀÇ | ºñ±³¸®½ºÆ®

º£Æ®³²ÀÇ ÀǾàǰ ¹× ÀÇ·á ½ÃÀå

Vietnam Pharmaceuticals & Healthcare

¸®¼­Ä¡»ç Fitch Solutions, Inc.
¹ßÇàÁ¤º¸ ¿¬°£±¸µ¶ »óǰ ÄÚµå 970965
ÆäÀÌÁö Á¤º¸ ¿µ¹® 70 Pages
°¡°Ý
US $ 1,415 £Ü 1,608,000 PDF (Single User License) - Includes 3 FREE Quarterly Updates


º£Æ®³²ÀÇ ÀǾàǰ ¹× ÀÇ·á ½ÃÀå Vietnam Pharmaceuticals & Healthcare
¹ßÇàÁ¤º¸ : ÆäÀÌÁö Á¤º¸ : ¿µ¹® 70 Pages

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹®¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹®¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º£Æ®³²ÀÇ ÀǾàǰ ½ÃÀåÀº ±¹¹Î°Ç°­º¸Çè Á¦µµ ½ÃÇàÀ» ÅëÇØ °è¼Ó °³¼±µÇ°í ÀÖÀ¸¸ç, Àå±âÀûÀ¸·Îµµ Å« ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù. º£Æ®³²Àº ¿©·¯ Á¦¾à ±â¾÷¿¡°Ô Àå±âÀûÀÎ »ó¾÷ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº Àα¸¿Í ´ç±¹ÀÇ ÀǾàǰ ÅõÀÚ Áö¿øÀº Å« ¼ºÀåÀ» ÀÌ·ç±â À§Çؼ­ ºñ¿ÁÇÑ Åä¾çÀ» Á¦°øÇÏ´Â ÀϺο¡ Áö³ªÁö ¾Ê½À´Ï´Ù. ÇÑÆí ÀÌ ÀáÀçÀûÀÎ °¡´É¼ºÀº ÀûÀº ÀǾàǰ ÁöÃâ°ú ±ÔÁ¦ Á¦µµÀÇ ¸®½ºÅ©·Î ÀÎÇØ Á¦³×¸¯ Á¦¾à±â¾÷À» À§ÇÑ °ÍÀ̶ó°í »ý°¢ÇÒ ¼ö ÀÖ½À´Ï´Ù. COVID-19 ÆÒµ¥¹ÍÀº ÀǾàǰ°ú ÀÇ·á ºÐ¾ß ½Ö¹æ¿¡¼­ Àü±¹¹Î º¸Çè ´Þ¼º¿¡ Å« °É¸²µ¹ÀÌ µÉ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

  • Key View
  • º£Æ®³² ÀǾàǰ ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ
  • SWOT ºÐ¼®
  • »ê¾÷ ¿¹Ãø
  • ÀǾàǰ ½ÃÀå ¿¹Ãø
  • ÀÇ·á ½ÃÀå ¿¹Ãø
  • ó¹æ¾à ½ÃÀå ¿¹Ãø
  • ƯÇã ÀǾàǰ ½ÃÀå ¿¹Ãø
  • Á¦³×¸¯ ÀǾàǰ ½ÃÀå ¿¹Ãø
  • OTC ÀǾàǰ ½ÃÀå ¿¹Ãø
  • ÀǾàǰ ¹«¿ª ¿¹Ãø
  • ¾÷°è ¸®½ºÅ©/º¸»ó Áö¼ö
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Çõ½ÅÀû ÀǾàǰ ¸®½ºÅ©/º¸»ó Áö¼ö
  • º£Æ®³²ÀÇ Çõ½ÅÀû ÀǾàǰ ¸®½ºÅ©/º¸»ó Áö¼ö
  • ±ÔÁ¦ °³¹ß
  • ±ÔÁ¦ ¸®ºä
  • ½ÃÀå »óȲ °³¿ä

°æÀï ±¸µµ

  • ±â¾÷ °³¿ä
  • DHG Pharmaceutical
  • GlaxoSmithKline
  • Sanofi
  • Traphaco
  • Vietnam Pharmaceutical Corporation
  • º£Æ®³²ÀÇ Àα¸Åë°è Àü¸Á
  • ¿ë¾îÁý
  • Á¶»ç ¹æ¹ý
LSH 20.12.02

Key View: Vietnam's pharmaceutical market will see substantial growth over the long term as the country continues to improve access to healthcare and medicines through the implementation of its national health insurance scheme. Vietnam offers considerable longer-term commercial opportunities for a range of pharmaceutical players. Its large population number and authorities' support for pharmaceutical investment are just some of the factors that would provide a fertile ground for substantial volume and value growth. However, this potential will mostly attract generic drug companies, given the low pharmaceutical spending and regulatory regime risks. In addition, the Covid-19 outbreak will pose significant hurdles to universal healthcare achievement, as well as both the pharmaceuticals and healthcare sector, as the spread continues.

Table of Contents

  • Key View
  • Vietnam Pharmaceuticals Covid-19 Impact
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Market Forecast
  • Industry Risk/Reward Index
  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Vietnam Innovative Pharmaceuticals Risk/Reward Index
  • Regulatory Development
  • Regulatory Review
  • Market Overview

Competitive Landscape

  • Company Profile
  • DHG Pharmaceutical
  • GlaxoSmithKline
  • Sanofi
  • Traphaco
  • Vietnam Pharmaceutical Corporation
  • Vietnam Demographic Outlook
  • Pharmaceuticals & Healthcare Glossary
  • Pharmaceuticals & Healthcare Methodology
Back to Top
ÀüÈ­ ¹®ÀÇ
F A Q